Traditional dental composites are based on Bis-GMA (bisphenol A glycidyl methacrylate) and TEGDMA (triethylene glycol dimethacrylate), both of which leach into saliva during the first 24–72 hours post-placement and at low levels chronically thereafter. Bis-GMA is a BPA derivative with weak estrogenic activity. Newer alternatives — Ormocers (organically modified ceramics), giomers (glass ionomer + composite hybrids), and bioactive glass composites — claim reduced leaching. The ALETHEIA database needs to evaluate: do these alternatives genuinely reduce monomer exposure, or do they introduce different leachable compounds?
| Compound/Material | Type | Source | Concern | DB Status |
|---|---|---|---|---|
| Bis-GMA | Resin monomer | Composite base resin | Estrogenic activity (BPA derivative); leaches 5–50 μg/restoration in 24h | HIGH risk |
| TEGDMA | Diluent monomer | Composite viscosity modifier | Cytotoxicity, mutagenicity in Ames test at high concentrations | MODERATE |
| HEMA (2-hydroxyethyl methacrylate) | Adhesive monomer | Bonding agents | Contact sensitizer; 1.4% patch-test positive rate | MODERATE |
| Camphorquinone | Photoinitiator | Light-cure system | Cytotoxic to pulp cells in vitro | LOW–MOD |
| BPA (from Bis-GMA hydrolysis) | Degradation product | Salivary/enzymatic hydrolysis of Bis-GMA | Endocrine disruption at low doses | HIGH |
| UDMA (urethane dimethacrylate) | Alternative monomer | Bis-GMA replacement in some composites | Lower viscosity, lower estrogenicity | MODERATE |
| Ormocer matrix | Hybrid organic-ceramic | Admira Fusion (VOCO) | Reduced monomer release claimed; less clinical longevity data | Under review |
| Giomer matrix | Glass ionomer hybrid | Beautifil (Shofu) | Fluoride release benefit; aluminum leaching concern | Under review |
| Bioactive glass (45S5) | Ceramic additive | Experimental composites | Remineralization benefit; long-term durability unknown | Emerging |
Measure/compile monomer release data in artificial saliva (ISO 10993-12, FDA guidance) over time course: 1h, 24h, 7d, 30d, 6mo. Compare Bis-GMA/TEGDMA composites vs Ormocer vs giomer vs bioactive glass. Key metric: cumulative monomer release in μg per restoration over clinically relevant time frames.
Published studies measuring BPA and methacrylate metabolites in urine/saliva of patients with dental composites. Quantify actual human exposure and compare to endocrine-disruption thresholds (TDI for BPA: 0.2 ng/kg bw/day per EFSA 2023).
Alternatives must match traditional composites on: compressive strength (250–400 MPa), flexural strength (80–120 MPa), wear resistance, color stability, and clinical longevity (>10 year survival). A safer material that fails mechanically creates different patient harm.
Exposure reduction quantified: Specific fold-reduction (or lack thereof) in monomer leaching for each alternative material class
Risk-benefit framework: Materials that reduce chemical exposure but compromise mechanical performance → contextualized tradeoff, not blanket recommendation
DB update: Add dental_leaching_profile to relevant compounds with peak_release_rate, cumulative_24h, cumulative_chronic, saliva_study_count; update alternatives with quantified exposure reduction data
2 weeks — Systematic review, data extraction from ~60–80 dental materials papers
2 weeks — Salivary diffusion modeling, exposure calculations
1 week — Head-to-head alternative material assessment
1 week — Implement across dental compound and material entries
Complete research scope and database integration